The use of antiarrhythmic drugs for adult cardiac arrest: A systematic review

Resuscitation

Volumn 82, Issue 6, 2011, Pages 665-670

  Ong, Marcus Eng Hock ^a   Pellis, Tommaso ^b   Link, Mark S ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Amiodarone; Anti arrhythmia agents; Bretylium; Cardiac arrest; Cardiopulmonary resuscitation; Heart arrest; Lidocaine; Magnesium; Procainamide

Indexed keywords

ADRENALIN; AMIODARONE; BRETYLIUM; LIDOCAINE; MAGNESIUM; NIFEKALANT; PLACEBO; PROCAINAMIDE; SOTALOL;

ASYSTOLE; DATA BASE; DEFIBRILLATION; HEART ARREST; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSELESS ELECTRICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; SURVIVAL RATE; SYSTEMATIC REVIEW;

ADULT; ANTI-ARRHYTHMIA AGENTS; HEART ARREST; HUMANS;

EID: 79956080846     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.02.033     Document Type: Review

References (35)

1. Cummins R.O. The " chain of survival" concept: how it can save lives. Heart Dis Stroke 1992, 1:43-45.
2. Cummins R.O., Ornato J.P., Thies W.H., Pepe P. Improving survival from sudden cardiac arrest: the " chain of survival" concept. Circulation 1991, 83:1832-1847.
3. Eisenberg M.S., Horwood B.T., Cummins R.O., Reynolds-Haertle R., Hearne T.R. Cardiac arrest and resuscitation: a tale of 29 cities. Ann Emerg Med 1990, 19:179-186.
4. Nichol G., Thomas E., Callaway C.W., et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 2008, 300:1423-1431.
5. ILCOR Advanced life support. Resuscitation 2005, 67:213-247.
6. Morley P.T., Atkins D.L., Billi J.E., et al. Part 3: evidence evaluation process: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2008, 122(16 Suppl 2):S283-S290.
7. Richardson W.S., Wilson M.C., Nishikawa J., Hayward R.S. The well-built clinical question: a key to evidence-based decisions. ACP J Club 1995, 123:A12-13.
8. Dorian P., Cass D., Schwartz B., Cooper R., Gelaznikas R., Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002, 346:884-890.
9. Kudenchuk P.J., Cobb L.A., Copass M.K., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999, 341:871-878.
10. Nowak R.M., Bodnar T.J., Dronen S., Gentzkow G., Tomlanovich M.C. Bretylium tosylate as initial treatment for cardiopulmonary arrest: randomized comparison with placebo. Ann Emerg Med 1981, 10:404-407.
11. Somberg J.C., Bailin S.J., Haffajee C.I., et al. Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. Am J Cardiol 2002, 90:853-859.
12. Levine J.H., Massumi A., Scheinman M.M., et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. J Am Col Cardiol 1996, 27:67-75.
13. Rea R.S., Kane-Gill S.L., Rudis M.I., et al. Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias. Crit Care Med 2006, 34:1617-1623.
14. Pollak P.T., Wee V., Al-Hazmi A., Martin J., Zarnke K.B. The use of amiodarone for in-hospital cardiac arrest at two tertiary care centres. Can J Cardiol 2006, 22:199-202.
15. Ohshige K., Shimazaki S., Hirasawa H., et al. Evaluation of out-of-hospital cardiopulmonary resuscitation with resuscitative drugs: a prospective comparative study in Japan. Resuscitation 2005, 66:53-61.
16. Herlitz J., Ekstrom L., Wennerblom B., et al. Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival?. Resuscitation 1997, 33:199-205.
17. Weaver W.D., Fahrenbruch C.E., Johnson D.D., Hallstrom A.P., Cobb L.A., Copass M.K. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation 1990, 82:2027-2034.
18. Tahara Y., Kimura K., Kosuge M., et al. Comparison of nifekalant and lidocaine for the treatment of shock-refractory ventricular fibrillation. Circ J 2006, 70:442-446.
19. van Walraven C., Stiell I.G., Wells G.A., Hebert P.C., Vandemheen K. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? The OTAC study group. Ann Emerg Med 1998, 32:544-553.
20. Allegra J., Lavery R., Cody R., et al. Magnesium sulfate in the treatment of refractory ventricular fibrillation in the prehospital setting. Resuscitation 2001, 49:245-249.
21. Thel M.C., Armstrong A.L., McNulty S.E., Califf R.M., O'Connor C.M. Randomised trial of magnesium in in-hospital cardiac arrest Duke Internal Medicine Housestaff. Lancet 1997, 350:9087:1272-1276.
22. Fatovich D.M., Prentice D.A., Dobb G.J. Magnesium in cardiac arrest (the magic trial). Resuscitation 1997, 35:237-241.
23. Gorgels A.P., van den Dool A., Hofs A., et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996, 78:43-46.
24. Stiell I.G., Wells G.A., Hebert P.C., Laupacis A., Weitzman B.N. Association of drug therapy with survival in cardiac arrest: limited role of advanced cardiac life support drugs. Acad Emerg Med 1995, 2:264-273.
25. Hallstrom A.P., Cobb L.A., Yu B.H., Weaver W.D., Fahrenbruch C.E. An antiarrhythmic drug experience in 941 patients resuscitated from an initial cardiac arrest between 1970 and 1985. Am J Cardiol 1991, 68:1025-1031.
26. Haynes R.E., Chinn T.L., Copass M.K., Cobb L.A. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Am J Cardiol 1981, 48:353-356.
27. Olson D.W., Thompson B.M., Darin J.C., Milbrath M.H. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out-of-hospital ventricular fibrillation in a paramedic system. Ann Emerg Med 1984, 13:807-810. (pt 2).
28. Herlitz J., Bang A., Gunnarsson J., et al. Factors associated with survival to hospital discharge among patients hospitalised alive after out of hospital cardiac arrest: change in outcome over 20 years in the community of Goteborg, Sweden. Heart (British Cardiac Society) 2003, 89:25-30.
29. Morrison L.J., Deakin C.D., Morley P.T., et al. Part 8: advanced life support: 2010 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation 2008, 122(16 Suppl 2):S345-S421.
30. Hassan T.B., Jagger C., Barnett D.B. A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation. Emerg Med J 2002, 19:57-62.
31. Kovoor P., Love A., Hall J., et al. Randomized double-blind trial of sotalol versus lignocaine in out-of-hospital refractory cardiac arrest due to ventricular tachyarrhythmia. Intern Med J 2005, 35:518-525.
32. Skrifvars M.B., Kuisma M., Boyd J., et al. The use of undiluted amiodarone in the management of out-of-hospital cardiac arrest. Acta Anaesthesiol Scand 2004, 48:582-587.
33. Kowey P.R., Levine J.H., Herre J.M., et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995, 92:3255-3263.
34. Nademanee K., Taylor R., Bailey W.E., Rieders D.E., Kosar E.M. Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 2000, 102:742-747.
35. Tomlinson D.R., Cherian P., Betts T.R., Bashir Y. Intravenous amiodarone for the pharmacological termination of haemodynamically tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?. Emerg Med J 2008, 25:15-18.